Mauro Cozzolino completed his Ph.D. at the Institute of Neurobiology, CNR, Rome, Italy, in 2001, where he focused his research on the role of intracellular pathways activated by neurotrophins in the regulation of cell-cell adhesion and cell motility. In 2001 he joined the Laboratory of Neurochemistry at Fondazione Santa Lucia, Rome, Italy, where he began to work on amyotrophic lateral sclerosis (ALS) as a Postdoc and, since 2005, as a Research Scientist. Since then, Dr. Cozzolino has worked essentially on ALS, as testified by his authorship or coauthorship, in about 25 papers on this issue published in international peer-reviewed journals. In particular, his work has focused on the involvement of mitochondrial dysfunction and protein aggregation in ALS linked to SOD1 mutations. Very recently, he has started his own group at the Institute of Translational Pharmacology, CNR, Rome, where he holds a permanent position as a Research Associate, and has moved his attention to the role of RNA metabolism in ALS pathology linked to TLS/FUS, TDP43, and C9ORF72.
Biography Updated on 8 September 2012